Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Ganaxolone by Marinus Pharmaceuticals for Status Epilepticus: Likelihood of Approval
Ganaxolone is under clinical development by Marinus Pharmaceuticals and currently in Phase III for Status Epilepticus. According to GlobalData, Phase...
Data Insights
Ganaxolone by Marinus Pharmaceuticals for X Chromosome Disorders: Likelihood of Approval
Ganaxolone is under clinical development by Marinus Pharmaceuticals and currently in Phase III for X Chromosome Disorders. According to GlobalData,...